Real‐World Comparative Study of Apalutamide Versus Bicalutamide in Combination With Androgen Deprivation Therapy for Metastatic Hormone‐Sensitive Prostate Cancer
In real-world Japanese clinical practice, apalutamide demonstrated superior efficacy in delaying progression to CRPC compared to bicalutamide when combined with ADT for mHSPC, with manageable safety profiles.
Authors
- Hidetsugu Takahashi
- Katsuki Muramoto
- Kota Katsumi
- Kojiro Tashiro
- Wataru Fukuokaya
- JIKEI‐YAYOI Collaborative group
- Takafumi Yanagisawa
- Fumihiko Urabe
- Keiichiro Mori
- Takahiro Kimura
Institutions
- Jikei University School of Medicine (JP)
- Katsushika Medical Center (JP)
- The Jikei University Hospital (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/iju.70369
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00